Role of endogenous melatonin in pathophysiologic and oxidative stress responses to personal air pollutant exposures in asthmatic children.

Accepted

Journal Article (Journal Article)

Background

Heightening oxidative stress and inflammation is an important pathophysiological mechanism underlying air pollution health effects in people with asthma. Melatonin can suppress oxidative stress and inflammation in pulmonary and circulatory systems. However, the role of melatonin in the oxidative stress and physiological responses to air pollution exposure has not been examined in children with asthma.

Methods

In this panel study of 43 asthmatic children (5-13 years old), each child had 4 clinic visits with a 2-week interval between two consecutive visits. At each visit, urine samples were collected and subsequently analyzed for 6-sulfatoxymelatonin (aMT6s) as a surrogate of circulating melatonin and for malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) as two biomarkers of systemic oxidative stress. At each clinic visit, children were measured for pulmonary function and fractional exhaled nitric oxide (FeNO, a marker of pulmonary inflammation). None of the children reported to have taking melatonin supplementation. Concentrations of indoor and ambient PM2.5 and ozone (O3 ) were combined with individual time-activity data to calculate personal air pollutant exposures.

Results

We found that interquartile range increases in urinary MDA and 8-OHdG concentrations were associated with significantly increased urinary aMT6s concentrations by 73.4% (95% CI: 52.6% to 97.0%) and 41.7% (22.8% to 63.4%), respectively. Increases in daily personal exposure to O3 and to PM2.5 were each associated with increased urinary aMT6s concentrations. Increasing urinary aMT6s concentrations were associated with decreased FeNO and resonant frequency, indicating improved airway inflammation and lung elasticity, respectively.

Conclusion

The results suggest that systemic oxidative stress heightened by air pollution exposure may stimulate melatonin excretion as a defense mechanism to alleviate the adverse effects.

Full Text

Duke Authors

Cited Authors

  • He, L; Norris, C; Cui, X; Li, Z; Barkjohn, KK; Teng, Y; Fang, L; Lin, L; Wang, Q; Zhou, X; Hong, J; Li, F; Zhang, Y; Schauer, JJ; Black, M; Bergin, MH; Zhang, JJ

Published Date

  • June 2021

Published In

Volume / Issue

  • 773 /

Start / End Page

  • 145709 -

PubMed ID

  • 33940766

Electronic International Standard Serial Number (EISSN)

  • 1879-1026

International Standard Serial Number (ISSN)

  • 0048-9697

Digital Object Identifier (DOI)

  • 10.1016/j.scitotenv.2021.145709

Language

  • eng